Advertisement
"SciVerse is a start of a new journey for Elsevier where we plan toprovide customized search and discovery solutions and increaseinteroperability within our products and third party services," said JayKatzen, Managing Director, Academic & Government Products, Elsevier. "Werecognize that it is critical to involve the researchers and librarians inthe creation of solutions as they are in the best position to identify andaddress their search and discovery challenges. By providing our content APIslater this year, we will empower researchers and developers to build customapplications to enhance their workflow and share these applications with thescientific community within SciVerse."
Advertisement
A multi-phased initiative aimed at accelerating science throughapplications targeted to specific researcher needs, at launch SciVerse willinclude SciVerse Hub beta, a module that integrates ScienceDirect(http://www.sciencedirect.com/), Scopus (http://www.scopus.com/) and targetedweb content from Scirus, Elsevier's science-specific Internet search engine.SciVerse Hub beta allows for a single search across its integrated contentwith results ranked by relevancy and without duplication, saving valuableresearcher time.
Combining familiar resources with new efficiencies, SciVerse also enablesinteroperability among ScienceDirect, Scopus and the new SciVerse Hub beta.For example, ScienceDirect users who also subscribe to Scopus will now beable to access key author information without leaving the article, and linkdirectly into comprehensive lists of all an author's documents and citationsin Scopus.
SciVerse Hub beta will include three search and discovery applications atlaunch:
The initial applications offer an example of the possible solutions thatcan be built using content APIs and were developed by NextBio, a provider ofa SaaS (Software as a Service) platform for life sciences researchers whichincludes ontology-based semantic tools. Elsevier began collaborating withNextBio in 2009.
Elsevier will begin rolling out its APIs on SciVerse in Q4 of this yearincluding content APIs for ScienceDirect, Scopus, and SciVerse Hub beta. Inopening up this trusted content to development by the worldwide scientificand developer communities, SciVerse will allow for collaboration onapplications that meet specific researcher challenges and enable the creationof customized solutions for efficiently finding, using and re-using SciVersecontent.
"As a physician scientist, there is vast amount of information that isavailable for potential discoveries which has limited my ability to find andconsume the right information in the time I have available for research,"said Dr. Fatima Cody Stanford, Palmetto Health/ University of South CarolinaSchool of Medicine. "Applications that provide more intelligent results willsignificantly improve my workflow. I am very excited about the first SciVerseapplications and eager to see new additions as the larger community beginsdevelopment."
For more information about SciVerse, please visithttp://www.info.sciverse.com.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical andmedical information products and services. The company works in partnershipwith the global science and health communities to publish more than 2,000journals, including The Lancet (http://www.thelancet.com/) and Cell (http://www.cell.com/), and close to 20,000 book titles, including majorreference works from Mosby and Saunders. Elsevier's online solutions includeScienceDirect (http://www.sciencedirect.com/), Scopus (http://www.scopus.com/), Reaxys (https://www.reaxys.com/), MD Consult (http://www.mdconsult.com/)and Nursing Consult (http://www.nursingconsult.com/), which enhance theproductivity of science and health professionals, and the SciVal suite(http://www.scival.com/) and MEDai's Pinpoint Review (http://www.medai.com/),which help research and health care institutions deliver better outcomes morecost-effectively.
A global business headquartered in Amsterdam, Elsevier (http://www.elsevier.com/) employs 7,000 people worldwide. The company is partof Reed Elsevier Group PLC (http://www.reedelsevier.com/), a world-leadingpublisher and information provider, which is jointly owned by Reed ElsevierPLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam),REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).- Integrates ScienceDirect, Scopus and Targeted Web Content; Offers New Search and Discovery Applications - - Opening APIs to Encourage Development of Customized Solutions -
SOURCE Elsevier
